
Validea's guru fundamental report assigns STRYKER CORP (SYK) an 81% rating from its Multi-Factor Investor model, based on Pim van Vliet's low-volatility, high-momentum, and high-net payout yield strategy. While this score typically indicates 'some interest' for a large-cap growth stock in Medical Equipment & Supplies, SYK's detailed assessment revealed mixed performance against specific criteria, including passes on market cap and standard deviation, neutrality on momentum and net payout yield, and notably, a 'FAIL' on the strategy's final rank criterion.
Stryker Corp (SYK) receives a moderately favorable 81% rating from Validea's Multi-Factor Investor model, which is based on Pim van Vliet's strategy of targeting low-volatility stocks with strong momentum and high net payout yields. This score signifies a degree of interest, falling just above the 80% threshold. The analysis reveals a mixed performance against the model's specific criteria. SYK successfully passes on its large market capitalization and low standard deviation, aligning with the core 'low volatility' tenet of the strategy. However, it receives neutral ratings for both 'Twelve Minus One Momentum' and 'Net Payout Yield', indicating it does not strongly exhibit the other two key factors sought by the model. Critically, despite the positive attributes and the overall score, the stock ultimately receives a 'FAIL' on the model's 'FINAL RANK' criterion, suggesting that it does not pass the strategy's holistic assessment.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment